1,796 Shares in CME Group Inc. (NASDAQ:CME) Bought by Intellectus Partners LLC

Intellectus Partners LLC bought a new stake in CME Group Inc. (NASDAQ:CME) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 1,796 shares of the financial services provider’s stock, valued at approximately $396,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Koshinski Asset Management Inc. acquired a new position in shares of CME Group in the 1st quarter valued at $244,000. Kingsview Wealth Management LLC grew its stake in CME Group by 21.9% in the first quarter. Kingsview Wealth Management LLC now owns 3,513 shares of the financial services provider’s stock valued at $756,000 after acquiring an additional 632 shares during the period. Nicolet Advisory Services LLC increased its holdings in shares of CME Group by 15.0% in the first quarter. Nicolet Advisory Services LLC now owns 1,496 shares of the financial services provider’s stock worth $314,000 after acquiring an additional 195 shares in the last quarter. Intech Investment Management LLC raised its position in shares of CME Group by 16.2% during the first quarter. Intech Investment Management LLC now owns 17,304 shares of the financial services provider’s stock worth $3,725,000 after purchasing an additional 2,412 shares during the period. Finally, Westfield Capital Management Co. LP lifted its holdings in shares of CME Group by 6.6% during the 1st quarter. Westfield Capital Management Co. LP now owns 25,793 shares of the financial services provider’s stock valued at $5,553,000 after purchasing an additional 1,593 shares in the last quarter. Institutional investors own 87.75% of the company’s stock.

CME Group Stock Up 0.8 %

CME stock opened at $225.28 on Friday. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $230.36. The company has a debt-to-equity ratio of 0.09, a current ratio of 1.02 and a quick ratio of 1.02. The stock has a market capitalization of $81.12 billion, a price-to-earnings ratio of 23.69, a PEG ratio of 5.26 and a beta of 0.55. The business’s fifty day moving average price is $222.52 and its two-hundred day moving average price is $210.26.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, topping analysts’ consensus estimates of $2.65 by $0.03. The business had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.59 billion. CME Group had a net margin of 57.34% and a return on equity of 13.39%. CME Group’s revenue for the quarter was up 18.4% compared to the same quarter last year. During the same period last year, the firm earned $2.25 earnings per share. On average, equities analysts anticipate that CME Group Inc. will post 10.23 earnings per share for the current year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Monday, December 9th will be paid a $1.15 dividend. This represents a $4.60 annualized dividend and a dividend yield of 2.04%. The ex-dividend date of this dividend is Monday, December 9th. CME Group’s dividend payout ratio (DPR) is currently 48.37%.

Insider Buying and Selling

In other news, Director Bryan T. Durkin sold 7,593 shares of the business’s stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the transaction, the director now directly owns 55,607 shares in the company, valued at approximately $11,932,706.13. The trade was a 12.01 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Martin J. Gepsman sold 400 shares of the company’s stock in a transaction that occurred on Monday, November 4th. The stock was sold at an average price of $222.92, for a total transaction of $89,168.00. Following the sale, the director now directly owns 25,067 shares of the company’s stock, valued at approximately $5,587,935.64. This trade represents a 1.57 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 15,621 shares of company stock valued at $3,441,063 over the last 90 days. 0.30% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Several brokerages have recently issued reports on CME. Citigroup increased their price objective on shares of CME Group from $250.00 to $255.00 and gave the stock a “buy” rating in a research report on Thursday, October 24th. Oppenheimer lifted their price target on CME Group from $245.00 to $258.00 and gave the company an “outperform” rating in a research note on Thursday, October 24th. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $235.00 price target on shares of CME Group in a research note on Thursday, October 24th. Deutsche Bank Aktiengesellschaft decreased their price objective on CME Group from $227.00 to $226.00 and set a “hold” rating for the company in a report on Monday, November 11th. Finally, JPMorgan Chase & Co. upped their target price on CME Group from $187.00 to $191.00 and gave the stock an “underweight” rating in a report on Thursday, July 25th. Four investment analysts have rated the stock with a sell rating, seven have given a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat, CME Group currently has an average rating of “Hold” and an average price target of $224.47.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.